Alan Huang, PhdCo-Founder & CEO, Sesame Therapeutics

Dr. Alan Huang is the Co-Founder and CEO of Sesame Therapeutics, a precision oncology company leveraging cancer-specific molecular proximity to develop highly selective therapies. Previously, he served as CSO of Tango Therapeutics, where he built a leading CRISPR-based functional genomics platform, advanced multiple first-in-class therapies into the clinic and helped take the company public. Prior to Tango, he was Global Head of Oncology Translational Research at Novartis, leading global teams to support drug development through biomarker strategy, patient selection, and translational science. Over his 20+ year career, Dr. Huang has played key roles in advancing oncology drug discovery from early target validation to clinical development and IPO.